Dr. Banaei's current research interests include development and implementation of rapid diagnostic assays for the detection, identification, and susceptibility testing of clinically important mycobacteria and uderstanding the role of M. tuberculosis lipoproteins in the pathogenesis of tuberculosis.

Dr. Bambos's current technology research interests include high-performance networking, autonomic computing, and service engineering.

The Baker lab's main focus is to understand the signals necessary for patterning and specifying diverse cellular fates during gastrulation in the mouse.

Dr. Kay's goal for the Program in Human Gene Therapy is to develop gene transfer technologies and use them for hepatic gene therapy for the treatment of genetic and acquired diseases.

Dr. Baccus's lab studies how the circuitry of the retina translates the visual scene into electrical impulses in the optic nerve.

Dr. Riitta Katila is the W. M. Keck Sr. Professor of Management Science, Faculty Director of the Stanford Technology Ventures Program and HAI Sabbatical Scholar at Stanford Institute for Human-Centered Artificial Intelligence at Stanford University. Her research is in the intersection of technology strategy and organizational learning, using machine learning, statistical analysis and mixed methods.

Dr. Kanan develops new catalysts and chemical reactions for applications in renewable energy conversion and CO₂ utilization.

Dr. Kamaya's current research is in photoacoustic imaging of cancer and perfusion CT imaging of abdominal tumors.

Dr. Ji's research group has embarked on a research initiative to use cutting edge genetics and technology to interrogate the fundamental genetic "digital" code responsible for cancer development and overall clinical behavior.

Dr. Jeffrey's research currently involves extracting and profiling circulating tumor cells (CTCs) from blood and bone marrow to shed light on the metastatic process and eventually to help guide selection of appropriate therapies in individual cancer patients.